✨ Dexmedetomidine Hydrochloride (CAS 145108-58-3) | Pharmaceutical-Grade Sedative Agent ✨
🧪 Product Overview
Dexmedetomidine Hydrochloride (CAS 145108-58-3) is a highly selective α2-adrenoceptor agonist with potent sedative and analgesic properties. This white to off-white crystalline powder (≥99% purity, HPLC) is widely used in critical care and perioperative settings to reduce anxiety and pain while maintaining patient responsiveness. Its molecular formula is C₁₃H₁₇ClN₂, with a molecular weight of 236.74.
Primary Functions:
Induces sedation without respiratory depression.
Reduces opioid requirements during surgery.
Enhances hemodynamic stability in ICU patients.
Target Industries: Pharmaceuticals, hospital care, anesthesia management.
⭐ Key Advantages
| 🔹 High Purity | 🔹 Global Compliance | 🔹 Flexible Packaging |
|---|
| ≥99% HPLC-certified | Meets USP/EP standards | 1g to 25kg bulk options |
| Batch-specific COA | ISO 9001 certified | Temperature-controlled shipping |
🏭 Applications
- Intensive Care
: Sedation for mechanically ventilated patients.
- Surgical Anesthesia
: Adjunct to general or regional anesthesia.
- Diagnostic Procedures
: Non-invasive sedation (e.g., MRI, CT scans).
📊 Quality Assurance
- Testing Protocols
: NMR, HPLC, mass spectrometry, and residual solvent analysis.
- Stability
: Long-term storage at
2-8°C in sealed containers.
- Regulatory Alignment
: Complies with ICH Q7 and GMP guidelines.
📈 Market Insights
The global sedation drugs market is projected to reach $6.2 billion by 2030, driven by increasing surgical volumes and ICU admissions. Dexmedetomidine demand is rising at 7.1% CAGR, particularly in Asia-Pacific regions due to expanding healthcare infrastructure.
China
